Astrantus’s CME Group CME Stock Holding History

Astrantus’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$381K	Buy	1,600 +700	+78%	+$164K	0.64%	65
2021 Q4	$206K	Buy	+900	New	+$198K	0.15%	205

Other funds holding CME

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Astrantus's CME Position: Q1 2022 in Review

Astrantus increased its CME Group (CME) stake by 78% in Q1 2022, buying an estimated $164K and bringing the position to 1,600 shares worth $381K. The position accounts for 0.64% of the portfolio, ranked #65.

Astrantus first reported a position in CME in Q4 2021 and has held it in 2 quarters since. 1,183 funds tracked by Wall St. Rank hold CME as of Q1 2022.

Astrantus held 1,600 shares of CME Group worth $381K as of Q1 2022.
Astrantus bought 700 CME Group shares in Q1 2022, an estimated $164K.
CME Group made up 0.64% of Astrantus's portfolio in Q1 2022, its #65 holding.
Astrantus first reported a position in CME Group in Q4 2021 and has held it in 2 quarters since.
1,183 funds tracked by Wall St. Rank held CME Group as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.